TRIM72 and gastric cancer: First, in more than 80% colorectal and gastric cancer patients tested, the protein level of MG53 is markedly decreased in the tumors compared with that in the adjacent normal tissues, and that MG53 expression level is significantly correlated with the survival outcome of the gastrointestinal cancer patients.